BioAgilytix, a leading provider of contract bioanalytical testing services, today announced the formation of an Advisory Board with deep scientific, commercial and regulatory expertise in the Biotechnology, Pharmaceutical and Contract…
BioAgilytix is honored to be named the 2014 CRO of the Year by the Triangle Business Journal in their 2014 Life Sciences Awards! This award recognizes BioAgilytix’s tremendous growth over…
BioAgilytix, a leading provider of contract bioanalytical testing services, today announced that Dominique Gouty has joined the company as Vice President of Business Operations, where she will hold key roles…
Learn about the MSD platform here.BioAgilytix, a leading bioanalytical testing laboratory specializing in immunoassays and cell-based assays, has validated Meso Scale Discovery’s V-PLEX™ Human Cytokine 30-plex assay, making it the…
BioAgilytix, a leading bioanalytical testing laboratory specializing in immunoassays and cell-based assays, announced today our support of development and release testing for biosimilar large molecule therapeutics. “Our expanded capability and…
BioAgilytix, a leading provider of contract bioanalytical testing services, today announced that Kelley Intehar has joined the company as Senior Director of Product Management. Kelley is a seasoned science and…
BioAgilytix, a leading provider of contract bioanalytical testing services, today announced that Jim Datin has joined the company as Chief Executive Officer. Jim is a seasoned executive with significant experience…
BioAgilytix, a leading bioanalytical testing laboratory specializing in immunoassays and cell-based assays, announced today the introduction of two Gyrolab xP workstations to its existing suite of immunoassay platforms. Dr. Afshin Safavi,…
Platforms
Services